HK2 and hepatocellular carcinoma: On the other hand, Compound K suppressed Akt/mTOR/c-Myc pathway and key glycolytic enzymes such as Hexokinase 2 (HK2) and pyruvate kinase isozymes M2 (PKM2), thereby thwarting HCC progression [191].